Yunzhong Qian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunzhong Qian has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Yi Chen
Department of General Surgery, National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
2 shared publicationsAo Dong
Department of General Surgery, National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publicationBinbin Yang
Department of General Surgery, National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine
1 shared publicationJianbing Wang
Department of General Surgery, National Clinical Research Center for Child Health, National Children's Regional Medical Center, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China
1 shared publicationJinfa Tou
MS, Department of General Surgery, The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Design of the study, acquisition of data, statistical analysis, critical revision, final approved
1 shared publicationLinyang Wang
MS, Department of General Surgery, The Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Design of the study, acquisition of data, statistical analysis, critical revision, final approved
1 shared publication
Latest Publications
- Open Access
- 11 October 2022
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 993450
Case report: Local bleomycin injection: A possible treatment option for primitive myxoid mesenchymal tumor of infancy
In recent years, it has been determined that primitive myxoid mesenchymal tumors of infancy (PMMTI) are solid tumors. To date, very few cases of PMMTI have been reported, and there is no consensus regarding treatment. To provide additional references, it is necessary to collect and report the diagnoses and treatment outcomes of related cases. We report the case of a 38-day-old girl who presented with a 5-cm purple tumor in the right shoulder. Upon hospital admission, the patient received an intratumoral injection of bleomycin after diagnosis of a possible lymphangioma. 10 days after the treatment, the tumor began to develop inflammation and necrosis, resulting in a clear demarcation between the tumor and surrounding tissue. Hence, during the second hospitalization, we performed a successful tumor resection. Postoperatively, the tumor was pathologically diagnosed as PMMTI. 3 months after excision, the patient showed no local recurrence on re-examination. To the best of our knowledge, this is the first report of a PMMTI in which bleomycin, or other similar chemotherapeutic drugs, have been injected into tumors. This result offers novel insights into the treatment of PMMTI. Injection therapy with bleomycin and similar chemotherapeutics may result in specific responses to PMMTI, which may help in developing better surgical conditions or improving outcomes in non-surgical patients.
- 11 October 2022
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 10, 993450
Open AccessCase report: Local bleomycin injection: A possible treatment option for primitive myxoid mesenchymal tumor of infancy
In recent years, it has been determined that primitive myxoid mesenchymal tumors of infancy (PMMTI) are solid tumors. To date, very few cases of PMMTI have been reported, and there is no consensus regarding treatment. To provide additional references, it is necessary to collect and report the diagnoses and treatment outcomes of related cases. We report the case of a 38-day-old girl who presented with a 5-cm purple tumor in the right shoulder. Upon hospital admission, the patient received an intratumoral injection of bleomycin after diagnosis of a possible lymphangioma. 10 days after the treatment, the tumor began to develop inflammation and necrosis, resulting in a clear demarcation between the tumor and surrounding tissue. Hence, during the second hospitalization, we performed a successful tumor resection. Postoperatively, the tumor was pathologically diagnosed as PMMTI. 3 months after excision, the patient showed no local recurrence on re-examination. To the best of our knowledge, this is the first report of a PMMTI in which bleomycin, or other similar chemotherapeutic drugs, have been injected into tumors. This result offers novel insights into the treatment of PMMTI. Injection therapy with bleomycin and similar chemotherapeutics may result in specific responses to PMMTI, which may help in developing better surgical conditions or improving outcomes in non-surgical patients.
- Open Access
- 1 July 2018
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 33 (7) , 556-564
Effects of baicalin on inflammatory reaction, oxidative stress and PKDl and NF-kB protein expressions in rats with severe acute pancreatitis
Key words: Pancreatitis; Oxidative Stress; Protein Kinases; NF-kappa B; Rats
- 1 July 2018
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 33 (7) , 556-564
Open AccessEffects of baicalin on inflammatory reaction, oxidative stress and PKDl and NF-kB protein expressions in rats with severe acute pancreatitis
Key words: Pancreatitis; Oxidative Stress; Protein Kinases; NF-kappa B; Rats